Circ_0007432通过SRSF1/KLF12轴促进非小细胞肺癌的进展和巨细胞M2极化
Shanshan Mao1,2, Dongyu Wu1, Xiaozhen Cheng2
1Radiotherapy Department, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, Hainan Province, P.R. China.
iScience
|May 27, 2024
概括
循环RNAcirc_0007432通过增强细胞活力,迁移和M2巨细胞极化,促进非小细胞肺癌 (NSCLC) 的进展. 它稳定KLF12,导致IL-8释放增加,导致恶性行为.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 循环RNAs (circRNAs) 越来越多地被认为是它们在癌症发展中的作用.
- 非小细胞肺癌 (NSCLC) 是全球癌症相关死亡的主要原因.
- 了解NSCLC中circRNAs的特定功能对于开发向疗法至关重要.
研究的目的:
- 研究circ_0007432在非小细胞肺癌 (NSCLC) 进展中的作用和机制.
- 为了阐明涉及circ_0007432,SRSF1,KLF12和IL-8在NSCLC发病过程中的分子相互作用.
- 评估circ_0007432对瘤生长和M2巨细胞极化的影响.
主要方法:
- RNA结合蛋白免疫沉降 (RIP) 和染色体免疫沉降 (ChIP) 试验.
- 电泳运动移动转移试验 (EMSA) 和双光酶记者试验.
- 在体内瘤生长研究和救援实验,以验证分子相互作用和功能作用.
主要成果:
- 在体内,Circ_0007432显著促进NSCLC细胞活力,迁移,入侵和瘤生长.
- Circ_0007432增强了M2巨细胞的两极分化,并抑制了NSCLC细胞的亡.
- 在机械上,circ_0007432通过招募SRSF1来调节KLF12,这反过来又促进IL-8的表达和释放.
结论:
- 在NSCLC中,Circ_0007432通过调节SRSF1/KLF12/IL-8信号轴作为瘤促进剂.
- 这种circRNA通过M2巨分化影响癌细胞恶性和瘤免疫微环境.
- 针对circ_0007432/SRSF1/KLF12/IL-8通路可能为NSCLC提供一种新的治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K


